Insurance can cover TRT — including testosterone medication, lab work, and office visits — but coverage depends on having the right diagnosis code, meeting specific lab thresholds, and navigating prior authorization requirements that vary by insurer.
The Diagnosis Code
Insurance coverage for TRT requires a hypogonadism diagnosis. The relevant ICD-10 codes:
- E29.1: Testicular hypofunction (primary hypogonadism — testicular failure)
- E23.0: Hypopituitarism (secondary hypogonadism — pituitary/hypothalamic cause)
- E89.5: Postprocedural testicular hypofunction (post-surgical)
The code must be supported by documented lab values showing testosterone below the insurer's threshold (typically <300 ng/dL on two separate morning draws) and documented symptoms consistent with hypogonadism.
Prior Authorization
Most insurers require prior authorization for testosterone prescriptions. The typical requirements:
- Two documented morning testosterone levels below threshold (usually <300 ng/dL)
- Documented symptoms of hypogonadism
- Evidence that the low testosterone is not due to a reversible cause (obesity, medication, acute illness)
- A trial of lifestyle modification may be required before drug approval for borderline levels
What Insurance Typically Covers
| Component | Coverage | Notes |
|---|---|---|
| Testosterone cypionate (generic) | Usually covered after PA | $10–$40 copay |
| Lab work | Usually covered as diagnostic | May require specific diagnosis code on lab order |
| Office visits | Covered (endocrine or primary care) | Copay applies |
| Commercial brand-name T (Aveed, Kyzatrex) | Variable — often denied without appeal | Step therapy may require generic trial first |
| Compounded testosterone | Rarely covered | Most insurers don't cover compounding pharmacy products |
Insurance Coverage Strategy
- Get two documented morning testosterone draws below 300 ng/dL (fasting, before 10 AM)
- Ensure your provider uses the correct ICD-10 code (E29.1 or E23.0)
- Request generic testosterone cypionate (highest approval rate)
- If denied, appeal with supporting labs and symptom documentation
- Use HSA/FSA for any out-of-pocket costs — TRT is an eligible medical expense
The Bottom Line
Possible But Not Automatic
Insurance coverage for TRT is achievable with proper diagnosis documentation, appropriate lab values, and correct coding. Generic injectable testosterone has the highest approval rate. The process requires more administrative effort than self-pay telehealth, but can reduce annual TRT costs from $1,500–$3,000 to a few hundred dollars in copays. For men with qualifying labs and insurance, it's worth pursuing.